BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21619051)

  • 1. Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents.
    Trabulo S; Cardoso AM; Santos-Ferreira T; Cardoso AL; Simões S; Pedroso de Lima MC
    Mol Pharm; 2011 Aug; 8(4):1120-31. PubMed ID: 21619051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
    Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
    Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells.
    Rama AR; Prados J; Melguizo C; Burgos M; Alvarez PJ; Rodriguez-Serrano F; Ramos JL; Aranega A
    Biomed Pharmacother; 2011 Jul; 65(4):260-70. PubMed ID: 21723082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles.
    Yang Y; Gao Y; Chen L; Huang Y; Li Y
    Int J Pharm; 2011 Feb; 405(1-2):188-95. PubMed ID: 21130850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
    Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells.
    Cogno IS; Vittar NB; Lamberti MJ; Rivarola VA
    J Photochem Photobiol B; 2011 Sep; 104(3):434-43. PubMed ID: 21641815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe.
    Lamers F; van der Ploeg I; Schild L; Ebus ME; Koster J; Hansen BR; Koch T; Versteeg R; Caron HN; Molenaar JJ
    Endocr Relat Cancer; 2011 Oct; 18(6):657-68. PubMed ID: 21859926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.
    Lima RT; Martins LM; Guimarães JE; Sambade C; Vasconcelos MH
    Cancer Gene Ther; 2004 May; 11(5):309-16. PubMed ID: 15031723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY; Ma P; Liu XL
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells.
    Yang CT; Li JM; Weng HH; Li YC; Chen HC; Chen MF
    Cancer Gene Ther; 2010 Feb; 17(2):120-30. PubMed ID: 19730451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
    Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
    Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
    Yang W; Sun T; Cao J; Liu F
    Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells.
    Dong H; Yao L; Bi W; Wang F; Song W; Lv Y
    J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
    Yuan-Jing F; Nan-Shan H; Lian X
    Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.